Neil F. McFarlane serves as the President, Chief Executive Officer, and Director at ZEVRA THERAPEUTICS INC, a position he has held since joining the company. With a robust background in the biopharmaceutical industry, McFarlane has been instrumental in steering ZEVRA THERAPEUTICS INC towards its mission of developing transformative therapies for rare diseases. His leadership is characterized by a strategic vision that aligns with the company’s goals of advancing patient care and improving outcomes. Before joining ZEVRA THERAPEUTICS INC, McFarlane held various leadership roles in other prominent biopharmaceutical companies, where he honed his skills in drug development and commercialization. His career is marked by a series of successful product launches and strategic partnerships that have significantly contributed to the growth and success of the organizations he has been part of. McFarlane’s expertise in navigating the complex landscape of rare disease treatment has been a key asset to ZEVRA THERAPEUTICS INC. In his current role at ZEVRA THERAPEUTICS INC, McFarlane oversees the company’s overall operations and strategic direction. He is committed to fostering a culture of innovation and excellence, ensuring that the company remains at the forefront of rare disease research and development. Under his leadership, ZEVRA THERAPEUTICS INC has made significant strides in advancing its pipeline and bringing new treatments to patients in need. McFarlane’s dedication to improving the lives of those affected by rare diseases continues to drive the company’s success and mission forward.